Year: 2015
Type: dissertation
Study design: Observational Study
Abstract: Obesity and type 2 diabetes are serious global health threats.They associate closely with non-alcoholic fatty liver disease (NAFLD).Already 20-30% of individuals worldwide have non-alcoholic fatty liver (NAFL), which is the primary phenotype of NAFLD.However, it is not known why some people will develop non-alcoholic steatohepatitis (NASH), which can further progress to liver cirrhosis.NAFLD increases not only liver-related morbidity and mortality, but also cardiovascular diseases and cancers.The real prevalence of NASH is not known, since diagnosis of NASH needs a liver biopsy.A non-invasive method would be helpful not only for diagnostics, but also in population based studies, where liver biopsies cannot be obtained.Attempts have been made to develop different non-invasive diagnostic methods.Novel biomarkers could be related to pathogenesis of NASH.For example, changes in cholesterol and lipid metabolism have been observed in those with NASH.In this thesis, a non-invasive score was developed in a cohort of 296 obese individuals with all essential NASH-associated measurements and parameters available.A score consisting of PNPLA3 rs738409 genotype, aspartate aminotransferase (AST) and fasting insulin found NASH with a sensitivity of 72% and specificity of 74%.Next, the score was validated in an Italian population of 380 obese individuals.Finally, in the Finnish D2D population study the score estimated the prevalence of 5% for NASH in Finnish adult individuals, when used.Cytokeratin 18 (CK-18) has been stated to be the best biomarker for NASH.CK-18 found NASH rather well also in this study, but it did not improve the predictive value of the score.The potential of CK-18 as a marker of intervention effect in the liver was further tested in HEPFAT dietary intervention study.The value of CK-18 in predicting the effect of intervention in the liver was modest.Different lipid subclasses in lipoproteins and low molecular weight molecules were measured with nuclear magnetic resonance (NMR) spectroscopy in a population of 116 massively obese individuals.Total cholesterol concentration of large, medium and small VLDL, and large and medium LDL was associated with liver inflammation independently of steatosis.Ketone bodies were lower in those with NASH than in those with fatty liver.This suggests lower lipid oxidation and decreased mitochondrial function in those with NASH.The non-invasive score formed in this thesis could be used as a screening method of NASH together with serum CK-18 measurement.Awareness of the prevalence of NASH should put more focus on prevention and treatment of NAFLD in Finland.The association of cholesterol metabolism with NASH suggests that cholesterol metabolism should be the target of treatment in NASH.Finally, decreased lipid oxidation and increased ketolysis in those with NASH were observed.In summary, this thesis indicates that common NASH is associated with multiple alterations in lipid metabolism.
Author: Ville Männistö
Institution: University of Eastern Finland
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Keywords: nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, biomarkers, PNPLA3 rs738409, aspartate aminotransferase, fasting insulin, cytokeratin 18, lipoprotein subclasses, VLDL, low-density lipoprotein, ketone bodies, lipid oxidation, mitochondrial function, obesity, type 2 diabetes, liver inflammation, steatosis, NMR spectroscopy
Open Access status: green
OpenAlex ID: W3097233270
